Manufacturers Life Insurance Company, The Innoviva, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Innoviva, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 27,112 shares of INVA stock, worth $478,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,112
Previous 28,262 4.07%
Holding current value
$478,526
Previous $463,000 12.96%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$16.33 - $20.04 $18,779 - $23,046
-1,150 Reduced 4.07%
27,112 $523,000
Q2 2024

Aug 14, 2024
SELL
$14.4 - $16.4 $30,931 - $35,227
-2,148 Reduced 7.06%
28,262 $463,000
Q1 2024

May 14, 2024
BUY
$14.56 - $16.78 $97,857 - $112,778
6,721 Added 28.37%
30,410 $463,000
Q4 2023

Feb 13, 2024
SELL
$12.32 - $16.27 $7,182 - $9,485
-583 Reduced 2.4%
23,689 $379,000
Q2 2023

Aug 11, 2023
SELL
$11.39 - $13.72 $1,583 - $1,907
-139 Reduced 0.57%
24,272 $308,000
Q4 2022

Aug 11, 2023
SELL
$11.8 - $13.78 $1,203 - $1,405
-102 Reduced 0.42%
24,411 $323,000
Q4 2022

Feb 13, 2023
SELL
$11.8 - $13.78 $1,203 - $1,405
-102 Reduced 0.42%
24,411 $323,000
Q3 2022

Aug 11, 2023
SELL
$11.61 - $15.22 $4,527 - $5,935
-390 Reduced 1.57%
24,513 $284,000
Q3 2022

Nov 03, 2022
SELL
$11.61 - $15.22 $4,527 - $5,935
-390 Reduced 1.57%
24,513 $285,000
Q2 2022

Aug 11, 2023
BUY
$14.32 - $19.88 $102,158 - $141,823
7,134 Added 40.15%
24,903 $367,000
Q2 2022

Aug 15, 2022
BUY
$14.32 - $19.88 $102,158 - $141,823
7,134 Added 40.15%
24,903 $368,000
Q1 2022

Aug 11, 2023
SELL
$15.39 - $20.25 $102,220 - $134,500
-6,642 Reduced 27.21%
17,769 $343,000
Q1 2022

May 20, 2022
SELL
$15.39 - $20.25 $65,407 - $86,062
-4,250 Reduced 19.3%
17,769 $344,000
Q4 2021

Feb 16, 2022
SELL
$15.91 - $18.72 $41,875 - $49,271
-2,632 Reduced 10.68%
22,019 $380,000
Q3 2021

Nov 12, 2021
SELL
$13.06 - $17.24 $166,501 - $219,792
-12,749 Reduced 34.09%
24,651 $412,000
Q2 2021

Aug 12, 2021
SELL
$11.45 - $13.96 $2,530 - $3,085
-221 Reduced 0.59%
37,400 $502,000
Q1 2021

May 03, 2021
SELL
$11.06 - $12.87 $16,092 - $18,725
-1,455 Reduced 3.72%
37,621 $450,000
Q4 2020

Feb 12, 2021
BUY
$9.33 - $12.48 $9,525 - $12,742
1,021 Added 2.68%
39,076 $484,000
Q3 2020

Nov 09, 2020
SELL
$10.33 - $14.49 $8,873 - $12,446
-859 Reduced 2.21%
38,055 $398,000
Q2 2020

Aug 10, 2020
SELL
$11.49 - $15.26 $30,356 - $40,316
-2,642 Reduced 6.36%
38,914 $551,000
Q1 2020

May 15, 2020
BUY
$8.11 - $15.23 $14,857 - $27,901
1,832 Added 4.61%
41,556 $489,000
Q4 2019

Feb 14, 2020
SELL
$10.28 - $14.38 $14,268 - $19,959
-1,388 Reduced 3.38%
39,724 $562,000
Q3 2019

Nov 12, 2019
SELL
$10.05 - $14.55 $1,286 - $1,862
-128 Reduced 0.31%
41,112 $423,000
Q2 2019

Aug 14, 2019
SELL
$13.1 - $14.95 $61,818 - $70,549
-4,719 Reduced 10.27%
41,240 $600,000
Q1 2019

May 13, 2019
BUY
$13.69 - $20.06 $33,814 - $49,548
2,470 Added 5.68%
45,959 $644,000
Q4 2018

Feb 14, 2019
SELL
$13.96 - $18.26 $43,806 - $57,299
-3,138 Reduced 6.73%
43,489 $759,000
Q3 2018

Nov 14, 2018
SELL
$13.63 - $15.7 $79,912 - $92,049
-5,863 Reduced 11.17%
46,627 $710,000
Q2 2018

Aug 14, 2018
SELL
$13.44 - $17.59 $54,633 - $71,503
-4,065 Reduced 7.19%
52,490 $725,000
Q1 2018

May 15, 2018
SELL
$13.8 - $16.99 $31,698 - $39,026
-2,297 Reduced 3.9%
56,555 $943,000
Q4 2017

Feb 08, 2018
SELL
$11.73 - $14.75 $9,161 - $11,519
-781 Reduced 1.31%
58,852 $835,000
Q3 2017

Nov 14, 2017
BUY
$12.06 - $14.12 $719,173 - $842,017
59,633
59,633 $842,000

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.23B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email